KPRX
Kiora Pharmaceuticals, Inc. Common StockstockNASDAQ
traded on nasdaq capital market, stock symbol eyeg, eyegate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye. our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid ("cmha-s"), a modified form of the natural polymer hyaluronic acid ("ha"), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface. our first cmha-s-based product candidate, the eyegate ocular bandage gel ("obg"), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy ("prk") surgery. our initial product candidate from our second platform is egp-437, incorporates a reformulated topically active corticosteroid, dexamethasone
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.33 | 2026-11-12 | -37.98% | 6.138 |
| 1M | 2.38 | 2026-10-19 | -65.34% | 2.677 |
| 3M | 2.60 | 2026-08-19 | -68.28% | 2.119 |
| 6M | 2.52 | 2026-05-19 | -67.27% | 1.146 |
| 1Y | 1.92 | 2025-11-19 | -57.04% | 1.419 |
| 2Y | 3.23 | 2024-11-19 | -74.46% | — |
| 5Y | 500.40 | 2021-11-19 | -99.83% | 0.930 |
Kiora Pharmaceuticals, Inc. Common Stock (NASDAQ:KPRX) stock price today is $0.82, and today's volume is 119,744. KPRX is down 11.312% today. The 30 day average volume is 57,714. KPRX market cap is $3.65M with 4.42M shares outstanding.